Responses
Abstracts Accepted for Publication
Rheumatoid arthritis - anti-TNF therapy
AB0322 Preliminary Data on The Introduction of The Infliximab Biosimilar (CT-P13) To A Real World Cohort of Rheumatology Patients
Compose a Response to This Article
Other responses
No responses have been published for this article.